Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gaurav Das Gaiha, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Gaurav Gaiha and Vivek Naranbhai.
Gaurav Gaiha
Connection Strength
3.685
Vivek Naranbhai
  1. T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals. Cell. 2022 Mar 31; 185(7):1259.
    View in: PubMed
    Score: 0.995
  2. T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals. Cell. 2022 03 17; 185(6):1041-1051.e6.
    View in: PubMed
    Score: 0.985
  3. T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all prior infected and vaccinated individuals. medRxiv. 2022 Jan 05.
    View in: PubMed
    Score: 0.979
  4. Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines. J Infect Dis. 2022 Apr 01; 225(7):1141-1150.
    View in: PubMed
    Score: 0.249
  5. Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccines. medRxiv. 2021 Oct 13.
    View in: PubMed
    Score: 0.241
  6. Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses. Cell. 2021 08 19; 184(17):4401-4413.e10.
    View in: PubMed
    Score: 0.236
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.